FDA and surrogate endpoints in Alzheimer's disease.
Osborne
Randy
R
D000544:Alzheimer Disease / Q000628:therapy*; D015415:Biomarkers; D006801:Humans; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards*
D015415:Biomarkers